我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

“冠心颗粒”抗缺血/再灌注损伤作用及JNK蛋白信号通路在其中的调节作用

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2013年第5期
页码:
519-523
栏目:
基础研究
出版日期:
2013-09-25

文章信息/Info

Title:
Guanxinkeli protects myocardial cell from ischemia-reperfusion injury in rats via JNK signal pathway
作者:
张权宇韩雅玲
(沈阳军区总医院心内科,辽宁 沈阳 110016)
Author(s):
Zhang Quan-yu Han Ya-ling
(Department of Cardiology, General Hospital of Shenyang Millitary Region, Shenyang 110016, China)
关键词:
冠心颗粒缺血/再灌注损伤心功能指标大鼠
Keywords:
guanxinkeli ischemia/reperfusion injury coronary function index rat
分类号:
R542.2
DOI:
-
文献标识码:
A
摘要:
目的:观察具有抗心肌缺血/再灌注(I/R)损伤作用的中药“冠心颗粒”(GXKL)对心肌I/R损伤的拮抗作用及其可能的机制。方法: 将36只SD大鼠随机分为3组:对照组,I/R组及GXKL组,每组12只大鼠。制备大鼠离体心脏心肌I/R模型再灌注30 min时,分别检测①离体心脏功能指标:左室收缩压(LVDP)、心率(HR)、左室舒张末压(LVEDP)及心室内压最大变化率(±dp/dtmax);②心律失常评分;③应用生化法检测肌酸激酶(CK)和乳酸脱氢酶(LDH)的活性;④应用蛋白印迹法检测再灌注0 min时,心肌组织中JNK的磷酸化水平。结果: 与I/R组比较,GXKL组:①可明显提高I/R大鼠心肌中的±dp/dtmax[(2327.1±334.5) vs.(1823.1±499.8) mmHg/s,P<0.05],并明显改善LVDP、LVEDP等指标[LVDP:(39.6±9.1) vs.(24.2±10.1) mmHg,P<0.05;LVEDP:(19.9±9.9) vs.(31.0±9.4) mmHg,P<0.05];②可明显降低心律失常的评分(11.58±4.81 vs. 6.33±1.88,P<0.05);③可明显降低LDH和CK的水平[(282.2±29.6) vs.(222.9±30.2) U/L和(299.8±45.4) vs.(251.9±41.8) U/L,P<0.05];④可明显降低缺血心肌组织中磷酸化JNK的水平(0.75±0.07 vs.1.54±0.10,P<0.05)。结论: GXKL可明显改善缺血心肌抗缺血、缺氧的能力,增加心肌收缩力,减轻心律失常;其对离体心肌I/R的拮抗作用可能与JNK途径密切相关。
Abstract:
AIM:To study the protection due to guanxinkeli (GXKL) on myocardial ischemic and reperfusion injury. METHODS: Thirty six rats were randomly divided into three groups: control, ischemia reperfusion injury, and resveratrol. Rat hearts were subjected to 15 min ischemia and then followed by 30 min reperfusion. HR, LVDP, LVEDP and ±dp/dtmax were recorded before ischemia and at 30 min of reperfusion. Coronary effulent was collected before ischemia and at 30 min of reperfusion to measure the CK and LDH activity. The arrhythmia scores were determined. RESULTS: GXKL enhanced the LVEDP, LVDP and ±dp/dtmax. The arrhythmia score, CK and LDH activity were lower in the GXKL group than in ischemia and reperfusion group. JNK activity was also lower in the GXKL group. CONCLUSION: GXKL has protected isolated myocardial ischemia and reperfusion injury. The JNK signaling pathway may play an important role in the mechanism.

参考文献/References

[1]Cui G,Shan L,Hung M,et al.A novel Danshensu derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways[J].Int J Cardiol,2013 Jan 3.doi:pii: S0167-5273(12)01640-3. 10.1016/j.ijcard.2012.12.012.[Epub ahead of print].
[2]Zhou R,He LF,Li YJ,et al.Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction[J].J Ethnopharmacol,2012,139(2): 440-446.
[3]刘剑刚,张大武,李 捷,等.丹参、红花水溶性组分及配伍对大鼠心肌缺血/再灌注损伤作用的实验研究[J].中国中药杂志,2011,36(2):189-194.
[4]Chen G,Fu Y,Wu X.Protective effect of Salvia miltiorrhiza extract against renal ischemia-reperfusion-induced injury in rats[J].Molecules,2012,17(2):1191-1202.
[5]Qiao Z,Ma J,Liu H.luation of the antioxidant potential of Salvia miltiorrhiza ethanol extract in a rat model of ischemia-reperfusion injury[J].Molecules,2011,16(12):10002-10012.
[6]Chiu PY,Wong SM,Leung HY,et al.Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKCε/mK(ATP) pathway in rats[J].Phytomedicine,2011,18(11):916-925.
[7]Zhai CL,Zhang MQ,Zhang Y,et al.cyrrhizin protects rat heart against ischemia-reperfusion injury through blockade of HMGB1-dependent phospho-JNK/Bax pathway[J].Acta Pharmacol Sin,2012,33(12):1477-1487.
[8]Zhang QY,Wang W,Shi QX,et al.Antiarrhythmic effect mediated by κ-opioid receptor is associated with Cx43 stabilization[J].Crit Care Med,2010,38(12):2365-2376.
[9]Han B,Zhang X,Zhang Q,et al.Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion[J].Arch Cardiovasc Dis,2011,104(5):313-324.
[10]Johnson GL,Nakamura K.The c-jun kinase/stress-activated pathway:regulation,function and role in human disease[J].Biochim Biophys Acta,2007,1773(8):1341-1348.
[11]Shinoda M,Shimazu M,Matsuda S,et al.c-Jun N-terminal kinase activation during warm hepatic ischemia/reperfusion injuries in a rat model[J].Wound Repair Regen,2002,10(5):314-319.
[12]Ferrandi C,Ballerio R,Gaillard P,et al.Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats[J].Br J Pharmacol,2004,142(6):953-960.
[13]Kim SJ,Jeong CW,Bae HB,et al.Protective effect of sauchinone against regional myocardial ischemia/reperfusion injury: inhibition of p38 MAPK and JNK death signaling pathways[J].J Korean Med Sci,2012,27(5):572-575.
[14]Jeong CW,Yoo KY,Lee SH,et al.Curcumin protects against regional myocardial ischemia/reperfusion injury through activation of RISK/GSK-3β and inhibition of p38 MAPK and JNK[J].J Cardiovasc Pharmacol Ther,2012,17(4):387-394.

备注/Memo

备注/Memo:
收稿日期:2013-06-04.通讯作者:韩雅玲,教授,主要从事缺血性心脏病研究 Email:hanyl@medmail.com.cn 作者简介:张权宇,主治医师,硕士 Email:qyzhang1983@gmail.com
更新日期/Last Update: 2013-09-30